Lopez A Y, Wang X, Xu M, Maheshwari A, Curry D, Lam S, Adesina A M, Noebels J L, Sun Q-Q, Cooper E C
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Department of Zoology and Physiology, University of Wyoming, Laramie, WY, USA.
Mol Psychiatry. 2017 Oct;22(10):1464-1472. doi: 10.1038/mp.2016.233. Epub 2016 Dec 13.
ANK3, encoding the adaptor protein Ankyrin-G (AnkG), has been implicated in bipolar disorder by genome-wide association studies. ANK3 has multiple alternative first exons, and a bipolar disorder-associated ANK3 variant has been shown to reduce the expression of exon 1b. Here we identify mechanisms through which reduced ANK3 exon 1b isoform expression disrupts neuronal excitation-inhibition balance. We find that parvalbumin (PV) interneurons and principal cells differentially express ANK3 first exon subtypes. PV interneurons express only isoforms containing exon 1b, whereas excitatory principal cells express exon 1e alone or both 1e and 1b. In transgenic mice deficient for exon 1b, PV interneurons lack voltage-gated sodium channels at their axonal initial segments and have increased firing thresholds and diminished action potential dynamic range. These mice exhibit an Ank3 gene dosage-dependent phenotype including behavior changes modeling bipolar disorder, epilepsy and sudden death. Thus ANK3's important association with human bipolar susceptibility may arise from imbalance between AnkG function in interneurons and principal cells and resultant excessive circuit sensitivity and output. AnkG isoform imbalance is a novel molecular endophenotype and potential therapeutic target.
ANK3基因编码衔接蛋白锚蛋白G(AnkG),全基因组关联研究表明其与双相情感障碍有关。ANK3有多个可变的首个外显子,且一种与双相情感障碍相关的ANK3变体已被证明会降低外显子1b的表达。在此,我们确定了ANK3外显子1b亚型表达降低破坏神经元兴奋-抑制平衡的机制。我们发现小白蛋白(PV)中间神经元和主细胞差异表达ANK3的首个外显子亚型。PV中间神经元仅表达包含外显子1b的亚型,而兴奋性主细胞仅表达外显子1e或同时表达1e和1b。在缺乏外显子1b的转基因小鼠中,PV中间神经元在其轴突起始段缺乏电压门控钠通道,其放电阈值增加,动作电位动态范围减小。这些小鼠表现出一种ANK3基因剂量依赖性表型,包括模拟双相情感障碍、癫痫和猝死的行为变化。因此,ANK3与人类双相情感障碍易感性的重要关联可能源于中间神经元和主细胞中AnkG功能的失衡以及由此导致的过度的回路敏感性和输出。AnkG亚型失衡是一种新的分子内表型和潜在的治疗靶点。